METHOD AND PREPARATION FOR THE TREATMENT OR PREVENTION OF ANXIETY OR NEUROGENESIS Russian patent published in 2017 - IPC A61K31/202 A61K31/405 A61K31/4415 A61K31/6615 A61K31/675 A61K31/685 A61P25/22 A61P25/24 A23L33/10 

FIELD: medicine.

SUBSTANCE: group of inventions refers to the use of a preparation, especially a nutritional preparation, for the prevention or treatment of anxiety or depression in a subject that is non-responsive to SSRI medication. It is disclosed the use of the preparation for production of the drug which contains: a) at least one ω-3-polyunsaturated fatty acid (PUFA); b) at least two phospholipids, selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine or any mixture thereof; and c) one or more compounds which are a factor in the serotonin metabolism, selected from the group of B vitamins and tryptophan. Also it is disclosed the use of the preparation for production of the drug of the same composition for regulating neurogenesis in an individual, which is characterized by reduction of serotonin transporter gene function.

EFFECT: technical result consists in efficiency of treating anxiety and similar depressive symptoms in the declared group of patients that are non-responsive on therapy by selective serotonin reuptake inhibitors (SSRI).

20 cl, 6 dwg, 1 tbl